Journal of Jilin University(Medicine Edition) ›› 2025, Vol. 51 ›› Issue (4): 939-947.doi: 10.13481/j.1671-587X.20250410
• Research in basic medicine • Previous Articles Next Articles
Jiarui LI,Zhenlin YANG,Fan GAO,Jingjing GUO,Jinzi LI(
)
Received:2024-11-14
Accepted:2024-12-27
Online:2025-07-28
Published:2025-08-25
Contact:
Jinzi LI
E-mail:yjzli@ybu.edu.cn
CLC Number:
Jiarui LI,Zhenlin YANG,Fan GAO,Jingjing GUO,Jinzi LI. Effect of miR-34a-5p on hippocampal neuron apoptosis in rats with temporal lobe epilepsy and its mechanism[J].Journal of Jilin University(Medicine Edition), 2025, 51(4): 939-947.
Tab.1
Positive expression rates of CDK6, p-Rb, and E2F1 proteins in hippocampus tissue of rats in various groups (n=3, x±s, η/%)"
| Group | Positive expression rate | ||
|---|---|---|---|
| CDK6 | p-Rb | E2F1 | |
| Control | 7.51±2.35 | 5.31±0.83 | 3.29±1.03 |
| Model | 25.23±1.70* | 15.67±1.58** | 11.85±1.54** |
| MiR-34a-5p inhibitor | 17.48±2.90△ | 10.80±1.85△ | 7.69±1.15△ |
| Inhibitor negative control | 29.24±2.97## | 14.65±1.23# | 10.86±1.02# |
Tab.2
Expression levels of CDK6,p-Rb,and E2F1 proteins in hippocampus tissue of rats in various groups"
| Group | CDK6 | p-Rb | E2F1 |
|---|---|---|---|
| Control | 0.34±0.13 | 0.22±0.10 | 0.16±0.04 |
| Model | 1.12±0.10* | 0.88±0.12* | 0.50±0.04* |
| MiR-34a-5p inhibitor | 0.70±0.09△△ | 0.61±0.11△ | 0.32±0.04△△ |
| Inhibitor negative control | 0.97±0.06# | 0.97±0.08# | 0.48±0.03## |
| [1] | 王一晰, 黄柏玮. 癫痫相关诱发机制及治疗方法的研究进展[J]. 中国实用神经疾病杂志, 2024, 27(9): 1168-1172. |
| [2] | BEGLEY C, WAGNER R G, ABRAHAM A, et al. The global cost of epilepsy: a systematic review and extrapolation[J]. Epilepsia, 2022, 63(4): 892-903. |
| [3] | KWAN P, ARZIMANOGLOU A, BERG A T, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies[J]. Epilepsia, 2010, 51(6): 1069-1077. |
| [4] | LEE S A, KIM M J, LEE H W, et al. The effect of recurrent seizures on cognitive, behavioral, and quality-of-life outcomes after 12 months of monotherapy in adults with newly diagnosed or previously untreated partial epilepsy[J]. Epilepsy Behav, 2015, 53: 202-208. |
| [5] | AL-KHALAF H H, COLAK D, AL-SAIF M, et al. p16(INK4a) positively regulates cyclin D1 and E2F1 through negative control of AUF1[J]. PLoS One, 2011, 6(7): e21111. |
| [6] | KROL J, LOEDIGE I, FILIPOWICZ W. The widespread regulation of microRNA biogenesis, function and decay[J]. Nat Rev Genet, 2010, 11(9): 597-610. |
| [7] | HO P T B, CLARK I M, LE L T T. microRNA-based diagnosis and therapy[J]. Int J Mol Sci, 2022, 23(13): 7167. |
| [8] | SALIMINEJAD K, KHORRAM KHORSHID H R, SOLEYMANI FARD S, et al. An overview of microRNAs: Biology, functions, therapeutics, and analysis methods[J]. J Cell Physiol, 2019, 234(5): 5451-5465. |
| [9] | JUCHNICKA I, KUŹMICKI M, NIEMIRA M, et al. miRNAs as predictive factors in early diagnosis of gestational diabetes mellitus[J]. Front Endocrinol (Lausanne), 2022, 13: 839344. |
| [10] | HU K, XIE Y Y, ZHANG C, et al. microRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted neuroprotection against hippocampal neurone cell apoptosis post-status epilepticus[J]. BMC Neurosci, 2012, 13: 115. |
| [11] | 郑微微, 高帆, 杨振林, 等. 新型抗癫痫药Q808对颞叶癫痫大鼠的改善作用及其机制 [J]. 吉林大学学报(医学版),2024, 50(5): 1243-1249. |
| [12] | CURIA G, LONGO D, BIAGINI G, et al. The pilocarpine model of temporal lobe epilepsy[J]. J Neurosci Methods, 2008, 172(2): 143-157. |
| [13] | BEARDEN D J, STASENKO A, PRENTICE F, et al. Mapping cognition in epilepsy: from the lab to the clinic[J]. Epilepsy Curr, 2024: 15357597241280485. |
| [14] | PERUCCA P, BAHLO M, BERKOVIC S F. The genetics of epilepsy[J]. Annu Rev Genomics Hum Genet, 2020, 21: 205-230. |
| [15] | TOMSON T, ZELANO J, DANG Y L, et al. The pharmacological treatment of epilepsy in adults[J]. Epileptic Disord, 2023, 25(5): 649-669. |
| [16] | FU J J, IMANI S, WU M Y, et al. MicroRNA-34 family in cancers: role, mechanism, and therapeutic potential[J]. Cancers (Basel), 2023, 15(19): 4723. |
| [17] | RIVADENEIRA D B, MAYHEW C N, THANGAVEL C, et al. Proliferative suppression by CDK4/6 inhibition: complex function of the retinoblastoma pathway in liver tissue and hepatoma cells[J]. Gastroenterology, 2010, 138(5): 1920-1930. |
| [18] | KOROTKOV A, MILLS J D, GORTER J A, et al. Systematic review and meta-analysis of differentially expressed miRNAs in experimental and human temporal lobe epilepsy[J]. Sci Rep, 2017, 7: 11592. |
| [19] | TOPACIO B R, ZATULOVSKIY E, CRISTEA S, et al. Cyclin D-Cdk4, 6 drives cell-cycle progression via the retinoblastoma protein’s C-terminal helix[J]. Mol Cell, 2019, 74(4): 758-770. |
| [20] | BEUKELAERS P, VANDENBOSCH R, CARON N, et al. Cdk6-dependent regulation of G(1) length controls adult neurogenesis[J]. Stem Cells, 2011, 29(4): 713-724. |
| [21] | ROUFAYEL R, MEZHER R, STOREY K B. The role of retinoblastoma protein in cell cycle regulation: an updated review[J]. Curr Mol Med, 2021, 21(8): 620-629. |
| [22] | MANDIGO A C, YUAN W, XU K X, et al. RB/E2F1 as a master regulator of cancer cell metabolism in advanced disease[J]. Cancer Discov, 2021, 11(9): 2334-2353. |
| [23] | 丛 明, 单 伟, 石玉秀. CDK4-p RB-E2F1通路在创伤后应激障碍大鼠杏仁核神经细胞凋亡中的作用[J]. 中国医科大学学报, 2021, 50(7): 608-611. |
| [24] | WU T Y, JIANG F L, WU F, et al. E2F1 and E2F7 regulate gastric cancer cell proliferation, respectively, through transcriptional activation and transcriptional repression of MYBL2[J]. J Biol Chem, 2025, 301(1): 108027. |
| [1] | Yang LI,Shiyang LI,Hongmei ZHANG,Qianqian LIU,Yubing CHEN. Effect of NGFR gene expression differences on promotion of apoptosis of squamous cell carcinoma and adenocarcinoma cells by PD-1 inhibitor-activated T lymphocytes [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 680-693. |
| [2] | Qiaotong REN,Weihua WU,Xingxiang WANG,Shichao WANG,Yipeng CHENG,Chun LI. Effect of interleukin-17 recepter B gene silencing on proliferation, invasion and apoptosis of lung adenocarcinoma A549 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 738-745. |
| [3] | Qiuping SU,Lei XING,Wei ZHANG,Shan JIANG,Yangyang ZHAO,Fangfang CHEN. Research progress in anti-tumor mechanism of berberine and application of its novel nano-delivery system in tumor therapy [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 863-871. |
| [4] | Jie YU,Zongkang WANG,Xun LIU,Yanan YANG,Jin TAN. Effect of miR-153-3p/PGC-1α axis on apoptosis of oral squamous cell carcinoma cells by modulation of mitochondrial apoptosis pathway [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 348-358. |
| [5] | Yaping LI,Chunyan TAN,Lujie ZHAO,Jiayi ZHAO,Ting LI,Xiao YANG,Xiaoyun YANG. Inductive effect of lysophosphatidic acid combined with 6-hydroxydopamine on apoptosis of SH-SY5Y cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 152-161. |
| [6] | Jiaxin WANG,Junwen MAO,Xuan ZHANG. Expression of natural autoantibodies against apoptosis inhibitory genes in plasma of patients with hepatocellular carcinoma and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 228-235. |
| [7] | Huaimin LIANG,Jiacheng JIN,Wenhua CHEN,Yuyao LI,Hangyu WANG,Ke ZHANG,Jinhui WANG. UPLC-Q-TOF/MS and network pharmacology analysis and experimental verification based on potential active ingredients and mechanisms of medicinal Mulberry Leaves in anti-acute kidney injury [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 56-69. |
| [8] | Shanshan SUN,Mei LU,Xinfu GAO,LYu Guangyao,Baolei Zhao,LYu Wenwen. Inhibitory effect of Bradykinin 1 receptor antagonist ELN441958 on proliferation of HepG2 cells by regulating Akt/FoxO3a signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 70-80. |
| [9] | Xiaohan YAO,Mingchen YAO,Zhiqing WANG,Heyang LI,Yan YAN,Ningjing LEI. Effect of silencing GPR139 gene on proliferation, apoptosis and autophagy of breast cancer cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 1-9. |
| [10] | Han XUE,Yuxin FAN,Ting ZHANG,Zhimin LI,Mingge HUO,Xingang GUAN. Preparation of nanodrug PTX2 NPs and its killing effect on human lung cancer A549 cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1260-1266. |
| [11] | Kun YANG,Qianyao FU,Yongqiang SUN,Kun YANG,Jun MENG. Protective effect of dexmedetomidine on intestinal mucosal injury in rats with enterogenous sepsis and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 855-865. |
| [12] | Panxi SUN,Xue QIN,Chongyang ZHANG,Jia LUO,Yong CHEN,Lili WEI. Protective effect of TUG-891 on ischemic stroke induced by ischemia and hypoxia and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 968-975. |
| [13] | Cheng CHEN,Jingyao LI,Wanxiang HU,Donghui LIU,Zhihong CHEN. Protective effect of sericin on streptozotocin-induced INS-1 cell damage by regulating PI3K/Akt/NF-κB signaling pathway through Akt1 and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(3): 590-598. |
| [14] | Donghui LIU,Yunzhe CI,Chunyan WANG,Wenyi MA. Effect of miR-199a-5p on expression of Caveolin-1, cell migration and apoptosis in glioma U251 cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(3): 663-671. |
| [15] | Shuyan SUN,Huakun ZHANG,Ziru ZHOU,Feng LI,Xiaobin CUI. Expression of CRNN protein in esophageal squamous cell carcinoma tissue and influence of its overexpression in biological behavior of esophageal squamous cell carcinoma Eca9706 cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(2): 275-283. |